OMVOH conc perf 300 mg/15ml flac 15 ml

7680689500010 CH-68950 L04AC24 07.15.0.

Reimbursement limitations:

OMVOHDstf.01

Seuls des médecins spécialistes en gastroentérologie ou des services de gastroentérologie des hôpitaux universitaires/policliniques peuvent …

OMVOH conc perf 300 mg/15ml flac 15 ml
OMVOH conc perf 300 mg/15ml flac 15 ml
OMVOH conc perf 300 mg/15ml flac 15 ml
1 / 3
google

Details

Product number
6895001
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
mirikizumabum 300 mg, natrii citras dihydricus, acidum citricum, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 15 ml corresp. natrium 60.02 mg.

Articles (1)

Omvoh 300 mg, solution à diluer pour perfusion
Lösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
01/07/2025
Professional SmPC
Français
01/07/2025
Professional SmPC
Italien
01/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
300.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
60.02 MG Substance HBESI

Reimbursement information

Public price
CHF 1248.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2024

Authorization holder

Eli Lilly (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
68950
Drug name
Omvoh, solution à diluer pour perfusion
Galenic form
KOINF
ATC Code
L04AC24
Authorization status
Z
Dispensation category
B
First authorization
30/11/2023
Authorization expiration date
29/11/2028
IT number
07.15.0.
Domain
Human medicine

Packaging details

Description (FR)
OMVOH conc perf 300 mg/15ml flac 15 ml
Description (DE)
OMVOH Inf Konz 300 mg/15ml Durchstf 15 ml
Market launch
30/11/2023
Narcotic (BTM)
No